A randomized, phase II study comparing irinotecan versus amrubicin as maintenance therapy after first-line induction therapy for extensive disease small cell lung cancer (HOT1401/NJLCG1401)

Baba, Keisuke; Tanaka, Hisashi; Fujita, Yuka; Nakamura, Atsushi; Kikuchi, Eiki; Kawai, Yasutaka; Harada, Toshiyuki; Watanabe, Naomi; Yokouchi, Hiroshi; Usui, Kazuhiro; Saito, Ryota; Watanabe, Hiroshi; Masuda, Tomomi; Fukuhara, Tatsuro; Kudo, Keita; Honda, Ryoichi; Oizimi, Satoshi; Maemondo, Makoto; Inoue, Akiri; Morikawa, Naoto

doi:https://doi.org/10.1093/annonc/mdz437.046

WEKO3

lat lon distance

[[sub_check.contents]]

[[sub_radio.contents]]

Field does not validate

[[sub_attr.contents]]　

インデックスツリー

アイテム

A randomized, phase II study comparing irinotecan versus amrubicin as maintenance therapy after first-line induction therapy for extensive disease small cell lung cancer (HOT1401/NJLCG1401)

https://iwatemed.repo.nii.ac.jp/records/2000842

Item type

会議発表論文 / Conference Paper(1)

公開日

2024-11-11

タイトル

A randomized, phase II study comparing irinotecan versus amrubicin as maintenance therapy after first-line induction therapy for extensive disease small cell lung cancer (HOT1401/NJLCG1401)

言語

eng

資源タイプ

資源タイプ識別子

http://purl.org/coar/resource_type/c_5794

資源タイプ

conference paper

アクセス権

metadata only access

アクセス権URI

http://purl.org/coar/access_right/c_14cb

著者

Baba, Keisuke
Tanaka, Hisashi
Fujita, Yuka
Nakamura, Atsushi
Kikuchi, Eiki
Kawai, Yasutaka
Harada, Toshiyuki
Watanabe, Naomi
Yokouchi, Hiroshi
Usui, Kazuhiro
Saito, Ryota
Watanabe, Hiroshi
Masuda, Tomomi
Fukuhara, Tatsuro
Kudo, Keita
Honda, Ryoichi
Oizimi, Satoshi
Maemondo, Makoto
Inoue, Akiri
Morikawa, Naoto

bibliographic_information

en : Annals of Oncology

巻 30, 号 Supplement 9, p. ix175-ix176, 発行日 2019-11

出版者

Elsevier Ltd

言語

item_10003_source_id_9

収録物識別子タイプ

PISSN

収録物識別子

0923-7534

Versions

Ver.1

2024-11-11 04:31:45.445842

Show All versions

Cite as

エクスポート

OAI-PMH

JPCOAR 2.0
JPCOAR 1.0
DublinCore
DDI

Other Formats

JSON
BIBTEX

インデックスリンク

インデックスツリー

アイテム

A randomized, phase II study comparing irinotecan versus amrubicin as maintenance therapy after first-line induction therapy for extensive disease small cell lung cancer (HOT1401/NJLCG1401)

× Baba, Keisuke

× Tanaka, Hisashi

× Fujita, Yuka

× Nakamura, Atsushi

× Kikuchi, Eiki

× Kawai, Yasutaka

× Harada, Toshiyuki

× Watanabe, Naomi

× Yokouchi, Hiroshi

× Usui, Kazuhiro

× Saito, Ryota

× Watanabe, Hiroshi

× Masuda, Tomomi

× Fukuhara, Tatsuro

× Kudo, Keita

× Honda, Ryoichi

× Oizimi, Satoshi

× Maemondo, Makoto

× Inoue, Akiri

× Morikawa, Naoto

Versions

Share

Cite as

エクスポート